Atlas Trials

Effect of CEAG on Inflammation and Endothelial Function

Clinical trial NCT03906825 · COMPLETED

Trial details

NCT number
NCT03906825
Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
InflammationEndothelial Dysfunction
Start date
2018-05-17
Primary completion
2018-08-13
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.